SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-030956
Filing Date
2022-06-02
Accepted
2022-06-02 16:30:07
Documents
3
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea160778-def14a_oramed.htm DEF 14A 435888
2 GRAPHIC image_001.jpg GRAPHIC 618753
3 GRAPHIC image_002.jpg GRAPHIC 477952
  Complete submission text file 0001213900-22-030956.txt   1947238
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 22991222
SIC: 2834 Pharmaceutical Preparations